, with radiochemical purity > 98% and mean specific radioactivity at the end of synthesis 3.7 ± 0.9 GBq/µmol. With this method the amounts of the reagents used in the synthesis are considerably reduced in comparison to other electrophilic labeling approaches. Thus the manipulations during the synthesis and the purification of the product are simplified.
Introduction
In 1983, 6-[
18 F]fluoro-L-DOPA ([ 18 F]FDOPA, 3) was first reported as a PET tracer for pre-synaptic dopaminergic functions and it is used in the study of Parkinson's disease [1] . Since then, many different procedures to synthesize [ 18 F]FDOPA have been developed (reviewed by [2, 3] ). [ 18 F]FDOPA has been synthesized by nucleophilic substitution [4] , by non-regioselective direct electrophilic substitution [5] or by electrophilic fluorodemetalation [6] [7] [8] [9] [10] . By the nucleophilic substitution method the specific radioactivity (SA) of the product is high (> 100 GBq/µmol) and the fluorinating agent, [ 18 F]F − , is easily produced by the 18 O( p, n) 18 F reaction. The method is, however, lengthy and requires many steps. The main difficulty is related to achieving sufficiently high enantiomeric purity. Enzymatic catalysis [11] or chiral phase-transfer alkylation [12] have been used to simplify the nucleophilic method, but the procedure is still long and complicated.
[ 18 F]FDOPA has been synthesized also by electrophilic [ 18 F]fluorodestannylation [7] . A stannylated, fully protected precursor was labeled using [ 18 [13] and for diagnosis of focal hyperinsulism of infancy [14] . In addition to the traditional uses as a neuroimaging tool, new applications for [ 18 F]FDOPA have made the tracer of current interest again. The increased clinical use of [ 18 F]FDOPA requires fast, high-yielding and easily automated synthesis methods. An automated synthesis module based on Namavari's method [7] has been developed by de Vries and colleagues [10] . In this automated system, the protected intermediate is used without further purification and the final semi-preparative purification is modified. In addition to the method of de Vries et al., other laboratories have utilized fluorodestannylation in order to produce [ 18 F]FDOPA [8, 15, 16] . We herein present our semi-automated modification of Namavari's method [7] 
Materials and methods

General
The general synthesis scheme of [ 18 F]FDOPA is presented in Fig. 1 .
The stannylated precursor, 4, (1) , and the reference compound, 6-fluoro-L-DOPA, were supplied from ABX (ABX GmbH, Radeberg, Germany). All the other reagents were purchased from commercial suppliers and were either synthesis grade or analytical grade and were used without further purification.
Semi-preparative HPLC was performed using a MerckHitachi L-7100 HPLC pump (Merck AG, Darmstadt, Germany) and a Waters µBondapak C18 column (7.8 × 300 mm, 10 µm, Waters Corp., Milford, MA, USA). A Merck-Hitachi L-7400 UV-absorption detector (λ = 280 nm) and a 2 × 2 in NaI-crystal for radioactivity detection were used. The col- umn was eluted with 0.9% NaCl-solution containing 0.01% acetic acid (flow rate of 3 mL/min). Analytical HPLC was conducted using a Merck-Hitachi L-7100 HPLC pump, an Inertsil ODS-2 column (4.0 × 150 mm, 5 µm, GL Science, Tokyo, Japan), a Merck-Hitachi L-7400 UV-absorption detector (λ = 280 nm) and a 2 × 2 in NaI-crystal for radioactivity detection. 0.07 M KH 2 PO 4 (aq) was used as an eluent (flow rate 0.85 mL/min).
A Supor Acrodisc (0.2 µm, 13 mm, Pall Corporation, NY, USA) sterile filter was used to formulate [
18 F]FDOPA for injection.
Tin contamination in HPLC fractions was analyzed by Inductively Coupled Plasma -Atomic Absorbtion Spectrometry (ICP/AAS). These analyses were carried out at the Department of Analytical Chemistry, Åbo Akademi University, Turku, Finland. 
Production of
Synthesis of [ 18 F]FDOPA
The stannylated precursor (1, 2.1-2.5 mg, 3.4-4.1 µmol) was dissolved in a mixture of trichlorofluoromethane (Freon-11, 700 µL) and dry acetic acid (25 µL). [ 18 F]F 2 was bubbled through this mixture at room temperature. Freon-11 was evaporated using neon flow and 300 µL of 47% HBr was added to the residue in order to deprotect compound (2). Hydrolysis was carried out at 130
• C for 5 min. The reaction mixture was then partially neutralized by addition of 100 µL 10.8 M NaOH and 300 µL HPLC eluent. With no further modifications, this solution was then loaded onto the preparative HPLC column.
[ 18 F]FDOPA (3) was purified by semi-preparative HPLC using the system described above. The 3 mL fraction containing the [
18 F]FDOPA was collected (Fig. 2a) and passed through the sterile filter into the end product vial.
Quality of [ 18 F]FDOPA
The amount of radioactivity, the pH and the volume of the end product were measured. A sample from the end product was evaluated by the analytical HPLC system described above. Determinations of chemical and radiochemical purity and SA were done by comparisons of HPLC retention times and peak intensities with a reference compound of known concentration. Radiochemical yields (RCY) were calculated from the initial amount of [ 18 F]F − and they were decay corrected to the end of bombardment (EOB). The SA of the product is decay-corrected to the end of the semi-preparative HPLC separation (EOS).
Enantiomeric purity of the product was confirmed on a CrownPak CR (+) HPLC column (150 × 4 mm, 5 µm, Daicel Chemical Industries LTD., Tokyo, Japan) eluted with 0.02 M HClO 4 (aq) at 0.7 mL/min.
Sterility and bacterial endotoxins were tested from 5% of the produced batches.
Tin content was analyzed from selected batches.
Results
The results of this study are analysed from 50 comparable syntheses of [ 18 
F]FDOPA (3). The initial [
18 F]F − activity ranged from 23 to 39 GBq (33 ± 4 GBq) and the average synthesis time was 50 ± 2 min including the synthesis of [ 18 F]F 2 , radiofluorination, the removal of the protecting groups, and the semi- preparative purification. In a semi-preparative HPLC purification (Fig. 2a) , the [ 18 F]FDOPA fraction eluting at 10.5 min was collected.
Radiochemical yield (decay corrected to EOB) was 6.4 ± 1.7% and radioactivity of [ 18 F]FDOPA (3) varied from 1008 to 2580 MBq (1544 ± 400 MBq) at EOS. The SA was 3.7 ± 0.9 GBq/µmol (2.1-6.0 GBq/µmol). From analytical HPLC studies (Fig. 2b) , the radiochemical purity (RCP) was determined to exceed 98% in all cases and the chemical purity with respect to L-DOPA > 95% in all cases. The final product was found to be sterile and endotoxine-free, and it was radiochemically stable for up to six hours. The enantiomeric purity exceeded 99%. Tin concentration of the final product varied from 5.8 to 12.6 µg/L (n = 5), with the bulk of tin eluting in the void fraction during the semi-preparative HPLC purification.
Discussion
New diagnostic uses of [ 18 F]FDOPA have aroused interest in simple and reproducible methods to produce it with high quantity. The drawbacks in the former methods of production of [ 18 F]FDOPA were either the complexity of the nucleophilic method or related to the poor SA achieved with the electrophilic method. As a consequence of the low SA, the chemical manipulations are cumbersome, involving large amounts of precursor, large amounts of the restricted solvent Freon-11, and difficult separation processes. Also in target production of electrophilic labeling agents has restricted the use of the electrophilic method. From our point of view, fluorodestannylation [7] by post-target produced [ 18 F]F 2 with moderately high SA [17] offers a solution to the abovementioned problems.
[ 18 F]F 2 has been found to be a better fluorinating agent than [ 18 F]CH 3 COOF in fluorodestannylation (radiochemical yields 25% and 8% respectively, [7] ). The method has been applied also in other laboratories [8, 10, 15, 16] . All groups produced [
18 F]F 2 by 20 Ne(d, α) 18 F reaction and used 97-180 µmol of the stannylated precursor dissolved in 10-20 mL Freon-11. The radiochemical yields were 25%-33% and SAs varied between 0.003-0.011 GBq/µmol [7, 8, 10, 15] .
In our studies, [18, 19] . Protecting groups were hydrolyzed with HBr as in previous studies [7, 8, 10, 15] , but less HBr was used and hydrolysis time was reduced by half. After neutralization, the volume of the reaction mixture was only 700 µL, small enough for the optimal resolution of FDOPA from L-DOPA in semi-preparative purification. NaCl-solution (0.9%) containing 0.01% acetic acid was used as HPLC eluent and only sterile filtration of the fraction containing (3) was needed before human use. The total tin content in the final product was of the order of 0.03 µg. According to reference 20 the estimate of daily oral exposure level of tributyl tin oxide posing minimal risk to humans is 0.3 µg/kg [20] .
In addition to the easier semi-preparative purification, smaller amounts of reagents offer other advantages. Because of the harmful effects of Freon-11 in the atmosphere, it is important to minimize its use. Also the evaporation of solvents before hydrolysis did not require either vacuum or elevated temperature. Recently Freon-11 has been succesfully replaced by deuterated chloroform [21] . Five minutes was sufficient for hydrolysis in our studies, although in previous work, hydrolysis time of less than 10 min resulted in incomplete hydrolysis [10] .
The present synthetic route is reproducible and [
18 F]FDOPA is produced an average of once per week in our laboratory for clinical use. Up to five human studies are performed from a single batch. The quality of the final product is analyzed from every batch before human injection and it has been found to be unchanged between batches. 18 F nuclear reaction. Modern low energy (k = 10-18) PET cyclotrons are mostly operated with proton beams, with some inconvenience in switching to deuteron beams. The radionuclide yield of 18 F for a given cyclotron in this energy range will be from 10 to 6 times higher using the oxygen reaction [22] . 18 
